Thousands of Xarelto Bottles Recalled Over Contamination Concerns

Rick Nemeroff Founder Published Apr 7, 2016

Late last month – on Tuesday, October 21 st – Johnson & Johnson’s Janssen unit announced a recall of the popular blood-thinner medication Xarelto (rivaroxaban). According to officials from Janssen, 13,500 bottles of Xarelto are being recalled after microbial contamination was found in a sample.

The U.S. Food and Drug Administration (FDA) also released an Enforcement Report confirming that the recall was prompted by a Xarelto sample which tested positive for microbial contamination. The contaminated sample – which came from a production plant in Puerto Rico – was tested after a customer filed a complaint.

Janssen, which has already faced a number of complaints involving Xarelto, issued a nationwide voluntary recall shortly after discovering evidence of contamination. According to an official statement, Janssen made the decision to recall the entire lot of bottles manufactured at its Puerto Rico facility, even though contamination was found in only one sample bottle.

More Concerns About Xarelto

Xarelto’s contamination recall is only the latest concern about the popular pharmaceutical, which has been heavily scrutinized for associated adverse effects. In recent years, Xarelto has been linked to cases of injury, hospitalization, and death due to issues of uncontrolled bleeding. These adverse events include cases of internal bleeding, subdural hemorrhaging, and severe bleeding that cannot be stopped. Many victims and families have begun filing lawsuits for the harm and suffering they experienced after taking Xarelto

Click here to find more information about Xarelto lawsuits.

Learn More About Xarelto Injuries & Your Rights

Nemeroff Law Firm has been dedicated to fighting on behalf of victims and families who’ve suffered preventable harm at the hands of Big Pharma. Our pharmaceutical injury attorneys are currently reviewing cases of victims who experienced adverse side effects – including uncontrolled bleeding that resulted in hospitalization or death – after taking Xarelto.

If you would like more information about filing a Xarelto lawsuit, your rights, and how Nemeroff Law Firm can help, contact our legal team today for a free case evaluation.

Written By

Rick Nemeroff

Rick Nemeroff, the firm’s founder, is a mesothelioma trial attorney who has won over $100 million for injured clients.

More About Rick Nemeroff

Related Content

Researchers Note Rise in Xarelto Prescriptions Despite Increase in Reports of Adverse Events

April 7, 2016 by Rick Nemeroff

In the past several months, concerns over the risks and safety of Xarelto – a popular prescription blood thinner – have been on the rise. In many cases, patients who took Xarelto have reported incidents of severe and uncontrollable bleeding, some serious enough to require hospitalization. A number of injuries and deaths have been associated […]

Xarelto Lawsuits Centralized in Louisiana

April 7, 2016 by Rick Nemeroff

Earlier this month, the U.S. Judicial Panel on Multidistrict Litigation announced the consolidation of federal Xarelto lawsuits in the United States District Court for the Eastern District of Louisiana. The announcement, made on December 12, is considered a turning point in nationwide litigation involving the popular blood-thinner, which has been linked to a number of […]

Takeda Pharmaceutical Agrees to $2.4 Billion Actos Settlement

March 21, 2016 by Rick Nemeroff

Late last month, Takeda Pharmaceutical Company – one of the largest pharmaceutical companies in the world – agreed to a $2.4 billion settlement to resolve thousands of lawsuits involving Actos. A popular prescription medication used to treat Type 2 diabetes, Actos has been associated with adverse side effects, including many cases of bladder cancer. The […]